ARK Genomic Revolution ETF Rating $23.68 +0.73 (+3.18%) (As of 12/20/2024 ET) Add Compare Share Share Ratings Stock AnalysisChartHeadlinesHoldingsOwnershipRatings ARK Genomic Revolution ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.ARKG Aggregate RatingModerate Buy 2.71Holdings in ARKG have an aggregate rating of Moderate Buy based on 429 analyst ratings issued in the past year covering 35 companies (99.8% of the portfolio).ARKG Aggregate Price Target$23.68High Prediction$23.68Average Prediction$23.68Low Prediction$23.68Holdings in ARKG have an aggregate price target of $23.68 and a range of $23.68 to $23.68 covering 35 companies (99.8% of the portfolio).ARKG Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy9 Buy rating(s)Moderate Buy21 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ARK Genomic Revolution ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 36 ARKG Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings9.47%TWSTTwist Bioscience$47.94+9.9%2.5561 of 5 stars2.70$51.90 8.3%10High Trading Volume7.80%CRSPCRISPR Therapeutics$40.72+0.8%2.5528 of 5 stars2.44$77.93 91.4%18Analyst ForecastHigh Trading Volume7.10%RXRXRecursion Pharmaceuticals$6.03-1.0%2.4151 of 5 stars2.40$9.25 53.4%5News CoverageHigh Trading Volume5.40%ADPTAdaptive Biotechnologies$6.39+6.5%2.9488 of 5 stars2.75$6.75 5.6%4Analyst ForecastNews CoverageGap Down5.20%VCYTVeracyte$40.89+4.7%4.0331 of 5 stars2.67$41.13 0.6%9Positive NewsHigh Trading Volume5.16%CDNACareDx$20.61+0.3%3.5915 of 5 stars2.43$29.60 43.6%7Positive NewsHigh Trading Volume4.84%NTRANatera$161.88+2.4%2.0763 of 5 stars3.00$152.67 -5.7%15High Trading Volume4.42%GHGuardant Health$31.67+1.7%4.115 of 5 stars3.00$40.60 28.2%154.16%SDGRSchrödinger$19.44+0.7%2.3678 of 5 stars2.82$32.90 69.2%11Positive News3.87%BEAMBeam Therapeutics$29.01+8.0%3.426 of 5 stars2.82$47.67 64.3%11High Trading Volume3.75%TEMTempus AI$35.54+7.6%2.7183 of 5 stars2.75$56.00 57.6%12Insider TradeGap UpHigh Trading Volume3.69%IONSIonis Pharmaceuticals$35.63+0.1%4.4164 of 5 stars2.68$60.65 70.2%19Analyst ForecastShort Interest ↓Analyst RevisionNews CoverageHigh Trading Volume3.63%TXG10x Genomics$14.04+3.2%4.4265 of 5 stars2.53$25.14 79.1%173.54%NTLAIntellia Therapeutics$12.18+0.8%4.2166 of 5 stars2.72$54.94 351.0%18High Trading Volume2.97%ARCTArcturus Therapeutics$15.48+4.3%2.5583 of 5 stars3.14$66.75 331.2%7Analyst ForecastNews Coverage2.74%NRIXNurix Therapeutics$19.83-1.0%2.5066 of 5 stars2.94$30.35 53.1%17News CoverageHigh Trading Volume2.11%PSNLPersonalis$5.75+9.3%3.9707 of 5 stars3.00$7.31 27.2%4Analyst ForecastNews CoverageGap UpHigh Trading Volume1.99%ABSIAbsci$2.99+2.4%1.8409 of 5 stars3.00$8.67 189.9%61.87%PACBPacific Biosciences of California$1.97+2.1%1.5488 of 5 stars2.50$2.95 50.0%121.83%BFLYButterfly Network$3.09+4.0%0.6687 of 5 stars3.00$3.00 -2.9%1Gap DownHigh Trading Volume1.64%VEEVVeeva Systems$224.15+2.0%4.8182 of 5 stars2.63$257.44 14.9%27Analyst ForecastPositive NewsHigh Trading Volume1.59%AMGNAmgen$263.38+0.8%4.4684 of 5 stars2.40$319.67 21.4%25Analyst DowngradeGap UpHigh Trading Volume1.43%ACCDAccolade$3.48+4.8%4.9011 of 5 stars2.79$8.96 157.4%14Analyst Forecast1.20%ILMNIllumina$136.02+1.5%4.482 of 5 stars2.70$165.95 22.0%20High Trading Volume1.11%CERSCerus$1.582.8085 of 5 stars2.75$3.63 129.4%41.00%INCYIncyte$68.84+2.7%4.7054 of 5 stars2.35$76.29 10.8%20Analyst ForecastHigh Trading Volume0.99%VRTXVertex Pharmaceuticals$397.27+0.2%4.7526 of 5 stars2.52$499.77 25.8%31Analyst ForecastAnalyst RevisionNews CoverageHigh Trading Volume0.99%QSIQuantum-Si$1.30+0.8%1.9199 of 5 stars2.50$3.25 150.0%2High Trading Volume0.85%REGNRegeneron Pharmaceuticals$701.85-0.9%4.6587 of 5 stars2.70$1,052.90 50.0%23Analyst ForecastHigh Trading Volume0.66%PRMEPrime Medicine$2.90+3.9%2.9953 of 5 stars3.00$12.67 336.8%11High Trading Volume0.65%CMPSCOMPASS Pathways$3.97+1.3%2.8299 of 5 stars3.00$33.60 746.3%6Positive News0.63%MASS908 Devices$2.06+6.2%1.9102 of 5 stars2.50$8.00 288.3%4News CoverageHigh Trading Volume0.55%RPTXRepare Therapeutics$1.323.4043 of 5 stars2.75$7.00 430.3%4High Trading Volume0.52%LABStandard BioTools$2.00+0.8%3.2471 of 5 stars3.00$2.88 43.8%2News CoveragePositive NewsGap Down0.41%EXASExact Sciences$59.40+5.9%4.4914 of 5 stars2.94$72.94 22.8%180.00%SNTISenti Biosciences$3.97-0.3%2.3392 of 5 stars3.00$10.00 151.9%1News CoverageGap Down This page (BATS:ARKG) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARK Genomic Revolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ARK Genomic Revolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ARKG Stock Alerts